New Delhi, Feb. 14 -- GlaxoSmithKline Pharmaceuticals Ltd (GSK) announced its financial results for the third quarter ended December 31, 2024, today, February 14, reporting an 18% increase in revenue from operations to Rs.946 crore.
(more to come)
Published by HT Digital Content Services with permission from MINT....
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.